Literature DB >> 19337310

Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study.

Wei-Liang Shih1, Ming-Whei Yu, Pei-Jer Chen, Tai-Wei Wu, Chih-Lin Lin, Chun-Jen Liu, Shi-Ming Lin, Dar-In Tai, Shou-Dong Lee, Yun-Fan Liaw.   

Abstract

A region on chromosome 4q25 has recently been highlighted as linked to hepatocellular carcinoma (HCC). In this study, we performed a family-based association analysis with 67 single-nucleotide polymorphisms (SNPs) to map this linkage region in 240 families with HCC, 212 (88.3%) of which were ascertained through hepatitis B virus surface antigen (HBsAg)-positive index cases. Individual SNP analysis with correction for multiple testing identified 10 SNPs in two correlated haplotype blocks, located in or around the 3'-phosphoadenosine 5'-phosphosulfate synthetase-1 (PAPSS1) gene (all P-values: <0.0075). Our linkage data and GIST (Genotype identity-by-descent sharing test) indicate that 6 of these 10 SNPs contributed to the linkage signal. The haplotype block of the strongest association with HCC extended from the intron 5 to the 3'-flanking region of PAPSS1; multiple consecutive three-SNP haplotypes in this region were significant. The most significant haplotype showed odd ratios of 3.41 (95% confidence interval (CI)=1.36-8.53) for homozygous individuals in a case-unaffected sibling analysis. This haplotype also revealed an association with elevated serum alpha-fetoprotein and with poor survival in familial cases and an independent series of HBsAg-positive cases with small tumor present at the time of hospital admission. These results implicate PAPSS1 as a candidate HCC-susceptibility gene in hepatitis B carriers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337310      PMCID: PMC2986632          DOI: 10.1038/ejhg.2009.48

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  36 in total

1.  Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection.

Authors:  M W Yu; I S Horng; K H Hsu; Y C Chiang; Y F Liaw; C J Chen
Journal:  Am J Epidemiol       Date:  1999-08-15       Impact factor: 4.897

Review 2.  Sulfonation and molecular action.

Authors:  Charles A Strott
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

3.  Pharmacogenetics of human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics.

Authors:  Zhen-Hua Xu; Bianca A Thomae; Bruce W Eckloff; Eric D Wieben; Richard M Weinshilboum
Journal:  Biochem Pharmacol       Date:  2003-06-01       Impact factor: 5.858

4.  Assessing whether an allele can account in part for a linkage signal: the Genotype-IBD Sharing Test (GIST).

Authors:  Chun Li; Laura J Scott; Michael Boehnke
Journal:  Am J Hum Genet       Date:  2004-02-06       Impact factor: 11.025

5.  A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.

Authors:  M W Yu; S Y Yang; Y H Chiu; Y C Chiang; Y F Liaw; C J Chen
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

6.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis.

Authors:  J R O'Connell; D E Weeks
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

7.  Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects.

Authors:  M W Yu; Y H Chiu; Y C Chiang; C H Chen; T H Lee; R M Santella; H D Chern; Y F Liaw; C J Chen
Journal:  Am J Epidemiol       Date:  1999-04-01       Impact factor: 4.897

8.  Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma.

Authors:  Ming-Whei Yu; Shi-Yi Yang; I-Jen Pan; Chih-Lin Lin; Chun-Jen Liu; Yun-Fan Liaw; Shi-Ming Lin; Pei-Jer Chen; Shou-Dong Lee; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

Review 9.  International variation.

Authors:  Donald M Parkin
Journal:  Oncogene       Date:  2004-08-23       Impact factor: 9.867

10.  Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk.

Authors:  Ming-Whei Yu; Hung-Chuen Chang; Shun-Chiao Chang; Yun-Fan Liaw; Shi-Ming Lin; Chun-Jen Liu; Shou-Dong Lee; Chih-Lin Lin; Pei-Jer Chen; Shee-Chan Lin; Chien-Jen Chen
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  5 in total

1.  p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.

Authors:  Xi Chen; Fei Liu; Bo Li; Yong-Gang Wei; Lv-Nan Yan; Tian-Fu Wen
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

2.  Prospective cohort studies of association between family history of liver cancer and risk of liver cancer.

Authors:  Yang Yang; Qi-Jun Wu; Li Xie; Wong-Ho Chow; Nat Rothman; Hong-Lan Li; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2014-03-07       Impact factor: 7.396

3.  Human PAPS synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm.

Authors:  Elisabeth Schröder; Lena Gebel; Andrey A Eremeev; Jessica Morgner; Daniel Grum; Shirley K Knauer; Peter Bayer; Jonathan W Mueller
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

4.  3'-Phosphoadenosine 5'-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding.

Authors:  Johannes van den Boom; Dominik Heider; Stephen R Martin; Annalisa Pastore; Jonathan W Mueller
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

Review 5.  Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer.

Authors:  Ada W. Y. Leung; Ian Backstrom; Marcel B Bally
Journal:  Oncotarget       Date:  2016-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.